K170614 is an FDA 510(k) clearance for the CareSens N Premier Blood Glucose Monitoring System, CareSens N Premier BT Blood Glucose Monitoring System. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).
Submitted by I-Sens, Inc. (Seoul, KR). The FDA issued a Cleared decision on October 19, 2017, 232 days after receiving the submission on March 1, 2017.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.